ORXOY – orexo ab sp/adr (US:NASDAQ)

News

Orexo initiates new study of OX640 in participants with allergic rhinitis [Yahoo! Finance]
Orexo initiates new study of OX640 in participants with allergic rhinitis
Orexo initiates new study of OX640 in participants with allergic rhinitis
Orexo AB reports Q3 results [Seeking Alpha]
Orexo Interim Report Q3 2024 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com